Fibroblast Senescence as a Therapeutic Target of Myocardial Fibrosis: Beyond Spironolactone?

J Am Coll Cardiol. 2016 May 3;67(17):2029-31. doi: 10.1016/j.jacc.2016.02.048.
No abstract available

Keywords: aging; fibroblast; gene expression; heart failure; tumor suppressor genes.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cardiomyopathies
  • Fibroblasts
  • Fibrosis*
  • Heart Failure
  • Humans
  • Mineralocorticoid Receptor Antagonists
  • Myocardium
  • Spironolactone*

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone